CAPRICOR THERAPEUTICS INC (CAPR) Stock Balance Sheet
NASDAQ:CAPR - Nasdaq - US14070B3096 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 68.38M | 14.69M | 9.60M | 34.89M | 32.67M | |||
| Marketable Securities | 16.65M | 24.79M | 31.82M | N/A | 0.00 | |||
| Receivables | 409.68K | 10.37M | 550.00K | 390.00K | 0.00 | |||
| Other Current Assets | 385.07K | 995.78K | 920.00K | 1.16M | 1.01M | |||
| Total Current Assets | 85.82M | 50.86M | 42.89M | 36.44M | 33.68M | |||
| Non-Current Assets | ||||||||
| PPE Net | 6.81M | 7.61M | 6.94M | 4.62M | 850.00K | |||
| Intangibles | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other Non-Current Assets | 319.25K | 268.17K | 270.00K | 280.00K | 90.00K | |||
| Total Non-Current Assets | 7.13M | 7.88M | 7.20M | 4.89M | 940.00K | |||
| TOTAL ASSETS | 92.95M | 58.73M | 50.09M | 41.33M | 34.62M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 250.00K | |||
| Accrued Expenses | 813.63K | 749.11K | 680.00K | 420.00K | N/A | |||
| Accounts Payable | 6.53M | 6.25M | 4.92M | 3.72M | 2.72M | |||
| Other Current Liabilities | 13.13M | 24.27M | 17.98M | N/A | N/A | |||
| Total Current Liabilities | 20.48M | 31.27M | 23.59M | 4.13M | 2.97M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 3.38M | 3.38M | 3.38M | 3.38M | 3.45M | |||
| Other Non-Current Liabilities | 834.89K | 1.49M | 11.35M | 2.45M | N/A | |||
| Total Non-Current Liabilities | 4.21M | 4.86M | 14.72M | 5.83M | 3.45M | |||
| TOTAL LIABILITIES | 24.69M | 36.13M | 38.31M | 9.96M | 6.42M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -192.72M | -159.37M | -137.08M | -108.06M | -88.04M | |||
| Additional Paid In Capital | 260.85M | 181.70M | 148.74M | 139.40M | 116.22M | |||
| Common Shares | 40.33K | 31.15K | 30.00K | 20.00K | 20.00K | |||
| Other Shareholders' Equity | 96.22K | 235.81K | 110.00K | N/A | 0.00 | |||
| Shares Outstanding | 40.33M | 31.15M | 25.24M | 24.19M | 20.58M | |||
| Tangible Book Value per Share | 1.69 | 0.73 | 0.47 | 1.30 | 1.37 | |||
| Total Shareholders' Equity | 68.26M | 22.60M | 11.79M | 31.37M | 28.20M | |||
| TOTAL LIABILITIES AND EQUITY | 92.95M | 58.73M | 50.09M | 41.33M | 34.62M | |||
| Statistics | ||||||||
| Debt/Equity | 0.05 | 0.15 | 0.29 | 0.11 | 0.12 | |||
| Current Ratio | 4.19 | 1.63 | 1.82 | 8.82 | 11.34 | |||
| Return On Assets (ROA) | -36.70% | -37.95% | -57.94% | -48.44% | -39.46% | |||
| Return On Equity (ROE) | -49.97% | -98.61% | -246.14% | -63.82% | -48.44% | |||
All data in USD , ROIC based on taxRate of 0.21